Additionally, analysis of the publicly available TCGA cohort confirmed our findings, demonstrating a positive association between KLF4 expression and RFS in HCC patients (p = 0.049, Figure 1I). This evidence concerns the gene KLF4 and hepatocellular carcinoma.